A consensus statement on the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) algorithm for the management of knee osteoarthritis—From evidence-based medicine to the real-life setting - Bruyère, Olivier; Cooper, Cyrus; Pelletier, Jean-Pierre; Maheu, Emmanuel; Rannou, François; Branco, Jaime; Luisa Brandi, Maria; Kanis, John A.; Altman, Roy D.; Hochberg, Marc C.; Martel-Pelletier, Johanne; Reginster, Jean-Yves (Seminars in arthritis and rheumatism, 2016)
Keywords: Acetaminophen - therapeutic use; Analgesics - therapeutic use; Chondroitin; Chondroitin Sulfates - therapeutic use; Evidence-Based Medicine; General & internal medicine; Glucosamine; Glucosamine - therapeutic use; Human health sciences; Humans; Hyaluronic acid; Knee osteoarthritis; Musculoskeletal Pain - prevention & control; Médecine générale & interne; Non-steroidal anti-inflammatory drugs; Osteoarthritis, Knee - drug therapy; Rheumatology; Sciences de la santé humaine; Symptomatic slow-acting drugs for osteoarthritis (SYSADOAs); Tramadol; Viscosupplements - therapeutic use; Glucosamine; Knee osteoarthritis; GS; pCGS; Chondroitin; Non-steroidal anti-inflammatory drugs; CS; SYSADOAs; Tramadol; IA; Symptomatic slow-acting drugs for osteoarthritis (SYSADOAs); HA; Hyaluronic acid; intra-articular; patented crystalline glucosamine sulfate; symptomatic slow-acting drugs for osteoarthritis; chondroitin 4&6 sulfate; glucosamine sulfate